These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38175966)

  • 1. COVID-19 Vaccination Rates Among North Dakota Residents Who Gave Birth Between April 1, 2021, and July 15, 2022.
    Aguilar O; Woinarowicz M
    Am J Public Health; 2024 Feb; 114(2):237-240. PubMed ID: 38175966
    [No Abstract]   [Full Text] [Related]  

  • 2. Using the North Dakota IIS to Assess the Response of Health Care Providers to the ACIP Recommendation for Tdap Vaccination During Pregnancy.
    Woinarowicz M; Howell M
    J Public Health Manag Pract; 2020; 26(2):153-158. PubMed ID: 31834203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using the North Dakota Immunization Information System to determine adolescent vaccination rates and uptake.
    LoMurray K; Sander M
    Public Health Rep; 2011; 126 Suppl 2(Suppl 2):78-86. PubMed ID: 21812172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
    Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events following third dose of mRNA COVID-19 vaccination among nursing home residents who received the primary series.
    Bardenheier BH; White EM; Blackman C; Gravenstein S; Gutman R; Sarkar IN; Feifer RA; McConeghy K; Nanda A; Duprey M; Mor V
    J Am Geriatr Soc; 2022 Jun; 70(6):1642-1647. PubMed ID: 35460263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
    McConeghy KW; White EM; Blackman C; Santostefano CM; Lee Y; Rudolph JL; Canaday D; Zullo AR; Jernigan JA; Pilishvili T; Mor V; Gravenstein S
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(39):1235-1238. PubMed ID: 36173757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing vaccination coverage of American Indian children with White children in North Dakota.
    Woinarowicz M; Howell M
    Public Health; 2020 Sep; 186():78-82. PubMed ID: 32791340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023.
    Moro PL; Carlock G; Fifadara N; Habenicht T; Zhang B; Strid P; Marquez P
    Vaccine; 2024 Apr; 42(9):2380-2384. PubMed ID: 38462432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COVID-19 vaccination in 4,772 pregnant women in the province of Trento (North-East Italy). Characteristics of vaccinated women.
    Pertile R; Battistella C; De Nisi M; Zuccali MG; Mantovani W; Moretti F
    Epidemiol Prev; 2023; 47(6):344-353. PubMed ID: 38314544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021.
    Lipkind HS; Vazquez-Benitez G; DeSilva M; Vesco KK; Ackerman-Banks C; Zhu J; Boyce TG; Daley MF; Fuller CC; Getahun D; Irving SA; Jackson LA; Williams JTB; Zerbo O; McNeil MM; Olson CK; Weintraub E; Kharbanda EO
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(1):26-30. PubMed ID: 34990445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
    Rosenblum HG; Wallace M; Godfrey M; Roper LE; Hall E; Fleming-Dutra KE; Link-Gelles R; Pilishvili T; Williams J; Moulia DL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Meyer S; Oliver SE; Twentyman E
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(45):1436-1441. PubMed ID: 36355612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Over-immunization in North Dakota's Adult Population.
    Dykstra A; Woinarowicz M; Howell M
    J Public Health Manag Pract; 2023 Nov-Dec 01; 29(6):915-921. PubMed ID: 37199429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Bookstein Peretz S; Regev N; Novick L; Nachshol M; Goffer E; Ben-David A; Asraf K; Doolman R; Levin EG; Regev Yochay G; Yinon Y
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):450-456. PubMed ID: 34198360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.
    Lakin KS; Wu Y; Gordon JK; Kwakkenbos L; Carrier ME; Henry RS; Denton CP; Mouthon L; Spiera RF; Thombs BD; ;
    Semin Arthritis Rheum; 2024 Aug; 67():152453. PubMed ID: 38851172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immunogenicity and reactogenicity of COVID-19 vaccines in pregnant women.
    Blakeway H; Amin-Chowdhury Z; Prasad S; Kalafat E; Ismail M; Abdallah FN; Rezvani A; Amirthalingam G; Brown K; Le Doare K; Heath PT; Ladhani SN; Khalil A
    Ultrasound Obstet Gynecol; 2022 Nov; 60(5):673-680. PubMed ID: 36318630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study.
    Yamin D; Yechezkel M; Arbel R; Beckenstein T; Sergienko R; Duskin-Bitan H; Yaron S; Peretz A; Netzer D; Shmueli E
    Lancet Infect Dis; 2023 Oct; 23(10):1130-1142. PubMed ID: 37352878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.
    Schiavoni I; Palmieri A; Olivetta E; Leone P; Di Lonardo A; Mazzoli A; Cafariello C; Malara A; Palamara AT; Incalzi RA; Onder G; Stefanelli P; Fedele G;
    J Am Med Dir Assoc; 2023 Feb; 24(2):140-147.e2. PubMed ID: 36587928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.